Transparency International (TI) has just released its 2018 Corruption Perception Index (CPI)[1]. The CPI continues to be an important gauge by companies in managing corruption risks when conducting businesses in foreign countries. TI reports that the Asia Pacific region has made little progress in the fight against corruption. With an…
On 26 October 2018, the Standing Committee of the National People’s Congress passed the revised PRC Criminal Procedure Law (“CPL”) which introduces, among other things, the “default judgment” and “immediate judgment” procedures in criminal trials. The default judgment procedure penalizes defendants who have absconded overseas in respect of bribery and…
The US Court of Appeals held that a non-resident foreign national cannot be guilty of violating the US Foreign Corrupt Practices Act as an accomplice or a co-conspirator if that person was incapable of committing it as a principal.
On 20 March 2018, China’s National People’s Congress passed the Supervision Law detailing the powers and responsibilities of the National Supervision Commission.
We provide an overview of the Transparency International annual CPI in relation to Asia Pacific countries focusing on the progress of China.
On 4 November 2017, the PRC Anti-Unfair Competition Law was amended providing more clarity on the scope of what constitutes commercial bribery. This post provides an insight on the key features of the new commercial bribery rules.
The PRC Supreme People’s Court and Supreme People’s Procuratorate have recently issued the Interpretation of Various Issues Concerning Application of Law in Handling Crimes of Infringing upon Citizen’s Personal Information.
The China Food and Drug Administration has issued guidelines aimed to implement China’s new Cybersecurity Law in the administration of medical devices in China. This development is a clear signal that Chinese regulators intend to enhance cybersecurity protection in the healthcare sector.
China has launched the “two-invoice” system in drug distribution on a trial basis, aiming to improve transparency in drug prices and eliminate excessive profit margins associated with multi-tier distribution models.
Transparency International has launched its latest 2016 Corruption Perception Index. China’s ranking continues to improve, moving up by four places from last year’s rank of 83 to a rank this year of 79. Find out more about the other highlights.